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Summary The RB1 gene mutation was investigated in a child with ectopic intracranial retinoblastoma using DNA obtained from both the
pineal and retinal tumours of the patient. A nonsense mutation in exon 17 (codon 556) of the RB1 gene was found to be present
homozygously in both the retinal and the pineal tumours. The same mutation was present heterozygously in the DNA from the constitutional
cells of the patient, proving it to be of germline origin. The initial mutation was shown to have occurred in the paternally derived RB1 allele.
The mutation is in an area of the gene that encodes the protein-binding region known as the 'pocket' region and has been detected in other
cases of retinoblastoma.
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Among the tumours developed by patients with retinoblastoma
(Rb) are intracranial neoplasms that have an identical histo-
pathological appearance to Rb. The existence of these 'ectopic
retinoblastomas' was first recognized by Jacobiec et al in 1977. In
1980, Bader et al suggested the term 'trilateral retinoblastoma' to
describe the clinical syndrome of bilateral Rb with an ectopic
midline intracranial tumour. They subsequently reported 11 chil-
dren with characteristics of trilateral Rb (Bader et al, 1982) and
suggested that the development ofan ectopic midline neuroblastic
tumour in apatient with bilateral Rb represents an additional focus
of multicentric Rb rather than a second primary tumour and drew
attention to the fact that the mammalian pineal gland has a
phylogenetic and ontogenetic relationship with photoreception
(Zimmerman et al, 1982). It was postulated that the mutant Rb
gene predisposes individuals to the development of neuroblastic
tumours that could arise in any cell ofphotoreceptor origin. It has
been proposed that ectopic Rb might arise mostly in the infant's
pineal but also more rarely elsewhere in the diencephalon from
germinal matrix cells nearthose thatnormally give rise to the optic
cup (Bullitt and Crain, 1981). The comparatively small number of
such cells in the pineal and their even smaller numbers in the
parasellar tissues would account for the relative scarcity ofectopic
Rbs even in genetically susceptible individuals (Zimmerman,
1985). In 1985, Kingston et al reported 12 ectopic intracranial Rb
from 630 children seen at St Bartholomew's and Moorfields Eye
Hospitals during a period of 30 years. Among 432 children with
bilateral Rb, the prevalence of trilateral Rb was 2.3%, which was
thought to be an underestimate, and a figure of4% was suggested
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Amoaku et al (1996) agreed with this figure. In the Dutch popula-
tion (in the period 1970-94), Moll et al (1996) found the cumula-
tive incidence ofpineoblastoma to be 9.3% at the age of5 years.
With the cloning of the RB1 gene in 1986 (Friend et al, 1986),
genetic screening and identification of causative mutations
became possible. Over the years, many RB1 mutations have been
identified by several groups using various techniques (Dunn et al,
1989; Yandell et al, 1989; Hogg et al, 1992; 1993; Onadim et al,
1992a; 1993; Blanquet et al, 1995; Lohmann et al, 1996). These
mutations were identified mainly in the constitutional or
retinoblastoma tumour tissue of Rb patients. There is only one
previous report of an RB1 mutation identified in the second
tumour of an Rb patient (Weir-Thompson et al, 1991) and, to the
best of our knowledge, no reports involving a pineoblastoma. In
this report, we describe the molecular RB1 gene analysis that was
carried out on the tissues obtained from a patient with ectopic
intracranial Rb seen at St Bartholomew's Hospital. As such, it
constitutes the first report on the actualRB1 mutation involved in a
case oftrilateral Rb.
CASE REPORT
A 13-month-old female infant presented in August 1992 with a
5-month history of an irregular left iris with subsequent onset of
clouding of the left pupil. There was no family history of eye
cancer or other malignancy.
On examination, she had evidence of left leucocoria and
objected to having her right eye covered. Her left eye was
glaucomatous with rubeosis iridis. Examination under anaesthetic
revealed that the left eye was full of tumour and the right eye
contained five tumours. Computerized tomographic (CT) scan of
the head and orbits showed enhancing, calcified masses in both
globes but no intracranial lesion. In particular, the pineal region
was normal. Her left eye was enucleated and histological
examination confirmed a well-differentiated retinoblastoma with
a predominantly endophytic growth pattern. The tumour had
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Figure 1 CT head scan of the patient showing a calcified mass in the pineal
region with marked triventricular hydrocephalus
invaded the optic nerve head but had not extended through the
lamina cribrosa. In addition, there was deep choroidal but no
scleral invasion. The four large posteriorpolar tumours in the right
eye were treated with lens-sparing external beam radiotherapy
(4400 cGy) and the smaller anterior lesion received cryotherapy.
Thereafter, the tumours remained inert and she remained well
until May 1995, when she presented with a 4-month history of
intermittent headaches. Examination at that time revealed a
swollen right disc and a spastic paraparesis. A CT head scan
revealed triventricular hydrocephalus with a large calcified mass
in the pineal region (Figure 1).
Surgery was undertaken with partial resection of the pineal
mass and insertion ofa Pudenz Shulte ventriculo-peritoneal shunt.
A subsequent myelogram after surgery showed total occlusion at
the upper border of L2 with multiple metastases throughout the
cervical and dorsal spine. Retinoblastoma cells were found in her
cerebrospinal fluid (CSF). Tumour material was sent for both
histological examination and DNA analysis. Histological exami-
nation revealed a small round cell tumour indistinguishable from
retinoblastoma. The results of the DNA analysis are detailed
below.
MATERIAL AND METHODS
DNA was prepared from whole blood and tumour tissues using
standard phenol-chloroform extraction and ethanol precipitation
(Sambrook et al, 1989). The tumour DNA was screened by
PCR-SSCP (polymerase chain reaction-single strand conforma-
tion polymorphism) and the mutation detected was identified by
sequencing. The general details of PCR-SSCP and sequencing
procedures have been described elsewhere (Hogg et al, 1992;
Onadim et al, 1993). The specific details and differences are
briefly summarized below.
DNA was amplified in GeneAmp PCR System 9600 (Perkin
Elmer). Primers for PCR were synthesized on a phophoramidite
column (ICRF, Central Services Division). The PCR reaction
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Figure 2 SSCP and sequencing of exon 17 of RB1. The SSCP gel (A) shows the Dra/digested exon 17 PCR products (from a number of unrelated Rb
patients) that were electrophoresed in a non-denaturing 6% polyacrylamide, 10% glycerol gel at 30 W at room temperature for 6 h. The sample from the
trilateral Rb patient is shown in lane 5 (arrow); it exhibits an abnormal banding pattern compared with the normal banding pattern shown in lanes 1-4 and 7-8.
Lane 6 also exhibits a different pattern and shows a mutation in another patient. In (B) the DNA sequence from the pineal tumour (P); retinal tumour (R) and
constitutional (C) cells of the patient is compared with a normal (N) DNA sequence for this part of exon 17. The patient shows C-iT change (arrow)
homozygously in DNA from the pineal (P) and the retinal (R) tumour and heterozygously in DNA from the constitutional cells. The faint band in the 'C' lane of
the retinal tumour is due to the presence of the residual normal cells in paraffin sections of the retinal tumour
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mixture consisted of approximately 100 ng DNA and 20 pmol of
each PCR primer. For SSCP, exon 17 ofRBl was amplified using
the following primers; RB5' EX17:5'-ACTTCCAAAAAAATAC-
CTAGCTCAAG-3' and RB3' EXl7:5'-CTCTCACTAA-
CAATAAT'T'TGTTAGCC-3'. A 'TaqStart' PCR was performed
using TaqStart Antibody (Clontech) to neutralize Taq DNA poly-
merase (Promega); 0.22 ,ug ofantibody and 1 unit ofTaq was used
per reaction. After denaturation at 95°C for 15 min, each PCR
reaction involved 35 cycles of denaturation at 94°C for 20 s,
annealing at 58°C for 20 s and extension at 72°C for 50 s. For
SSCP analysis, 334-bp exon 17 fragments weredigested with Dral
to produce smaller fragments (139+195 bp) to improve the sensi-
tivity. For sequencing an internal 5' exon 17 primer was used;
RB5' EX17INT: 5'-GATTTTTACAAAGTGATCGAAAG-3'.
For loss ofheterozygosity (LOH) analysis, the RB1.20 (Yandell
and Dryja, 1989) and the RBi.2 (Toguchida et al, 1993) polymor-
phisms of the RB1 gene were used. The PCR primers and the
procedures for the RB1.20 analysis were as described previously
(Onadim etal, 1992b). Theprocedure forthe detection ofthe RBi.2
polymorphism was essentially the same as the RB1.20, except that
the primers published in Toguchida et al (1993) were used.
RESULTS
DNA extracted from the pineal tumour ofthe patient was screened
for the RB1 mutation using PCR-SSCP together with DNAs from
other Rb patients and controls. The SSCP gel ofexon 17 exhibited
an abnormal banding pattern ofthe pineoblastoma DNA compared
with the other samples (Figure 2A). Sequencing revealed a
homozygous C-*T mutation incodon 556 (base 78250) ofthe RB1
gene (Figure 2B). This substitution converts an arginine codon
(CGA) to a stop codon (TGA) and as such occurs at a CpG dinu-
cleotide. The mutation also destroys a TaqI and a Hinflll site.
When blood DNA ofthe patient was sequenced, the same mutation
was present heterozygously (Figure 2B), as expected, demon-
strating that this is a germline mutation. The DNA from the Rb
tumour of the patient also exhibited the mutation homozygously
(Figure 2B). The mutation was absent in the blood DNA from both
the mother and the father ofthe patient (data not shown).
LOH analysis was carried outusing the RB1.20 and RBi.2 poly-
morphisms of RB1. The Rbi.2 was not informative but LOH in
both tumours was demonstrated with the RB1.20 (Figure 3). The
RB1.20 genotype of the patient is 1,4, having inherited allele
number 1 from her father and allele number 4 from her mother. As
shown in Figure 3, in both the pineal and the eye tumour, allele
number 4 was lost and allele 1 was retained indicating that the
initial mutation occurred in the paternally derived RB1 allele.
DISCUSSION
The RB1 mutation identified in this patient is a nonsense mutation
in exon 17 ofthe gene that codes for part ofthe 'pocket' region of
the Rb protein. The mutation was absent in the blood DNA from
both the father and the mother, indicating that it represents a new
germline mutation (although we can not exclude the possibility of
mosaicism). The mutation was shown to have occurred on the
copy ofthe RB1 gene derived from the father. This conforms with
the fact that new germline mutations in the RB1 gene (Dryja et al,
1989; Zhu et al, 1989; Kato et al, 1994) and in other loci (Vogel
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Figure 3 Segregation of alleles of the RB1 gene using the RB1.20 VNTR.
The number of the RB1.20 alleles are indicated on the left-hand side. The
patient's constitutional DNA (C) exhibits bands 1 and 4, which she has
inherted from her father (F) and mother (M) respectively. Both the pineal (P)
and the retinal (R) tumour (T) DNAs exhibit only allele number 1, i.e. the
paternally inherited allele
and Rathenberg, 1975) are generally found on the paternally
derived copy. The mean age at diagnosis for new germline carriers
of the RB1 mutation is 14 months (Draper et al, 1992) and Rb in
this patient was diagnosed when she was 13 months old. The
patient presented with the pineal tumour 32 months afterthe initial
diagnosis ofRb, which fits with the median interval of 34 months
reported by Kingston et al (1985).
TheRB1 mutation identifiedis aC-iTtransitionoccurring within
a CpG dinucleotide. High mutability of the CpG sites has been
reported fortheRB1 gene (Hogg et al, 1993; Cowell etal, 1994) and
for other genes (Cooper and Youssoufian, 1988; Cooper and
Krawczak, 1990). The mechanism involved is thought to be sponta-
neous hydrolytic deamination of 5-methylcytosine to thymine,
although local motifs, for example nearby repeat sequences, may
also play a role (Hogg et al, 1993; Onadim 1993). In this case,
misalignment with the 'TGAA' sequence 3 bp downstream of the
mutated 'CGAA' might have resulted in the C-*T substitution.
Recent reports of CpG methylation at the sites of recurrent muta-
tions in the NFl and the BRCA1 genes (Andrews et al, 1996;
Rodenhiseret al, 1996), however, support adeamination cause. This
mutation was first reported by Hogg et al (1993) as the somatic
mutation in the retinal tumour from a unilateral non-hereditary Rb
case. Subsequently, in the only two other reports ofthe same muta-
tion, it was identified as a germline mutation (Cowell et al, 1994;
Liu et al, 1995). It seems, therefore, that although this patient has
developed an ectopic Rb and as such is different from the other
'ordinary' Rb cases, theRB1 mutation she carries constitutes part of
the spectrum of RB1 mutations seen in other Rb phenotypes,
including non-hereditary ones. To date, only families exhibiting a
'mild phenotype' and lower penetrance of the RB1 mutation have
been shown to carry mutations that are different - missense and
promoterregionmutations orin-frame deletions that may not totally
abolish the function ofthe protein (Sakai et al, 1991; Onadim et al,
1992a; Dryja et al, 1993; Lohmann et al, 1994; Cowell et al, 1996).
There are limited previously published data on abnormalities in
pineoblastomas in the literature. Among these are structural abnor-
malities ofchromosome 1 (Griffinet al, 1988), 11 (Sreekantaiah et
al, 1989) and 17q (Kees et al, 1994). A tumour-related locus on 17
p13 - distinct from p53 - was also reported for some paediatric
neuroectodermal tumours (Biegel et al, 1992). We have examined
the status of the p53 gene in this pineoblastoma by performing
LOH analysis (using thep53 intron 1 VNTR - Hahn et al, 1995)
and by sequencing the four highly conserved regions reported to
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contain the majority of mutations in human tumours (exons 5-8:
codons 117-286, Hollstein etal, 1991). There was no LOH forp53
in eitherthe retinoblastoma orthe pineal tumour, and no p53 muta-
tions were detected in the pineal tumour in the conserved regions
studied (data not shown). The elucidation ofthe spectrum ofgenes
involved in the development of pineoblastomas and a better
assessment of mutational patterns in trilateral Rb awaits analysis
ofmore ofthese rare tumours.
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